1. Brown SD, Raeburn LA, Holt RA (2015) Profiling tissue-resident T cell repertoires by RNA sequencing. Genome Med 7:125
2. Callahan BM, Tong WL, Blanck G (2018a) T cell receptor-beta J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates. Immunol Res 66:219–223
3. Callahan BM, Yavorski JM, Tu YN, Tong WL, Kinskey JC, Clark KR, Fawcett TJ, Blanck G (2018b) T-cell receptor-beta V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns. CII, Cancer immunology
4. Chen SA, Tsai MH, Wu FT, Hsiang A, Chen YL, Lei HY, Tzai TS, Leung HW, Jin YT, Hsieh CL, Hwang LH, Lai MD (2000) Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine. Clin Cancer Res 6:4381–4388
5. Cheng L, Guo Y, Zhan S, Xia P, Association between HLA-DP gene polymorphisms and cervical cancer risk: a meta-analysis, Biomed Res Int, 2018 (2018) 7301595